-
Crafoord Prize laureates honoured for autoimmune disease work
08 Feb 2025 02:07 GMT
… are not affected by autoimmune diseases,” commented prize committee …
Recent encouraging developments have seen existing drugs harnessed to … the immune system in autoimmune disease, which “may also … foundations for understanding and treating disease.
“It’s …
-
Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500
07 Feb 2025 18:40 GMT
… the US Food and Drug Administration (FDA) in an end-of … anti-CD40L mAbs in development.”
With potential applications in … stem cell transplantation, and treating autoimmune diseases, TNX-1500 is currently … UPLIFT trial of TNX-601 ER for the treatment of …
-
Diabetes Clinical Trial Revolution | 200+ Companies Driving Breakthrough Therapies to Reshape Treatment
07 Feb 2025 16:47 GMT
… working to develop 200+ pipeline drugs for Diabetes treatment.
• The … diabetes medications, Mounjaro and Zepbound, is over. The FDA … Type 1 diabetes, an autoimmune disorder in which the immune … drug is in Phase III stage of its clinical trial for treating …
-
Diagnosing and Treating CNS cGVHD With Rituximab in Refractory Cases
07 Feb 2025 14:43 GMT
Photo Credit: MQ-Illustrations
The following is a summary of “Chronic graft-versus-host disease myelitis successfully treated with rituximab,” published in the January 2025 issue of Hematology by Yokoyama et al.
Chronic graft-versus-host disease (cGVHD) …
-
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
07 Feb 2025 13:30 GMT
… treatment of autoimmune diseases. Tonix also has product candidates in development … As with any pharmaceutical under development, there are significant … high blood pressure
medication overuse headaches from … of prescription drugs to the FDA. Visit www.fda.gov…
-
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
07 Feb 2025 13:00 GMT
… 2024, aims to revolutionize drug development by leveraging cutting-edge … drug repurposing, accelerate discovery, optimize solid-form identification, and enhance clinical trial … clinical trials in autoimmune disorders. About Conduit Pharmaceuticals Conduit is a …
-
Granzyme K identified as key trigger of complement system in autoimmune diseases
06 Feb 2025 17:47 GMT
Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system-a group of proteins that patrols our body, ever vigilant for signs of infection or …
-
Business : Zenas BioPharma Targets Key 2025 Milestones For Obexelimab In Autoimmune Diseases
06 Feb 2025 09:47 GMT
… the largest-ever clinical trial for Immunoglobulin G4-Related … from the Phase 2 SApHiAre trial.
Additionally, Zenas completed … out-licenced ZB005 for development in Greater China and … as a groundbreaking treatment for multiple autoimmune diseases with a once …
-
Study reveals how gut bacteria might trigger autoimmune diseases like lupus
05 Feb 2025 20:21 GMT
… new approaches for diagnosis and treatment of autoimmune diseases.
The study was published … biomarkers for autoimmune disease risk. They may also be targets for treating the … target the immune system when treating autoimmune diseases,” said Kriegel. “We may …
-
Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
05 Feb 2025 12:05 GMT
… the treatment of patients living with certain autoimmune diseases. During … the successful clinical development, approval and clinical … medication, including GCs.
More information on the Phase 3 INDIGO trial … SLE is an autoimmune disease characterized by B cell …